Inhibition of NAADP signalling on reperfusion protects the heart by preventing lethal calcium oscillations via two-pore channel 1 and opening of the mitochondrial permeability transition pore
- Cardiovasc Res. 2015 Dec 1;108(3):357-66. doi: 10.1093/cvr/cvv226.
- 1. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, UK [email protected].
- 2. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, UK.
- 3. School of Chemistry, University of Southampton, Highfield, Southampton, UK.
- 4. Department of Physiology, Li Ka Shing School of Medicine, The University of Hong Kong, Hong Kong, China.
- 5. School of Pharmacy, University of East Anglia, Norwich, UK.
- 6. Department of Cell and Developmental Biology, University College London, London, UK.
Aims: In the heart, a period of ischaemia followed by reperfusion evokes powerful cytosolic CA(2+) oscillations that can cause lethal cell injury. These signals represent attractive cardioprotective targets, but the underlying mechanisms of genesis are ill-defined. Here, we investigated the role of the second messenger nicotinic acid adenine dinucleotide phosphate (NAADP), which is known in several cell types to induce CA(2+) oscillations that initiate from acidic stores such as lysosomes, likely via two-pore channels (TPCs, TPC1 and 2).
Methods and results: An NAADP antagonist called Ned-K was developed by rational design based on a previously existing scaffold. Ned-K suppressed CA(2+) oscillations and dramatically protected cardiomyocytes from cell death in vitro after ischaemia and reoxygenation, preventing opening of the mitochondrial permeability transition pore. Ned-K profoundly decreased infarct size in mice in vivo. Transgenic mice lacking the endo-lysosomal TPC1 were also protected from injury.
Conclusion: NAADP signalling plays a major role in reperfusion-induced cell death and represents a potent pathway for protection against reperfusion injury.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Calcium ChannelResearch Areas: Cardiovascular Disease